IBBJ
Defiance Nasdaq Junior Biotechnology ETF
Set alert
29.87 USD 0.00 0.00%
29.86 Day range 29.90
52-week range unavailable
- Open
- 29.87
- Prev close
- 29.87
- Mkt cap
- 8.23M
- Vol
- 2.20K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 29.86
- High
- 29.90
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 29.33
- 200-d avg
- 30.95
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 29.33
- 200-day average
- 30.95
About Defiance Nasdaq Junior Biotechnology ETF
The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.
News
- ETF Odds & Ends: Closures Accelerate
- ETF Odds & Ends: Launches Resurge
- Biotech ETFs Benefit From Moderna Dual Booster Shot News
- Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News
- Bet on Biotech Small Caps to Bounce Back
- 7 Stocks to Buy Now if You're Feeling Greedy While Others Are Fearful
- Biotech Innovations Remain At Forefront
- Moving Beyond COVID In Biopharma
- Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast Transcript)
- Why Small Cap Biotech ETFs Are Still Brilliant Bets
Your note
Sign in to keep a note on IBBJ — it syncs with the Stock Master app.